Home › Ventricular Tachycardia › New York
Ventricular Tachycardia clinical trials in New York
6 studies for Ventricular Tachycardia are looking for participants at sites in New York.
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
- Northwell Health Lenox Hill Hospital, Manhasset
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 29, 2026 · NCT07585968Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia
- Westchester Medical Center, Valhalla
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07814079Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
- Northwell Health, Manhasset
Recruiting
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07324031Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
- Icahn School of Medicine at Mount Sinai, New York
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
- Northwell Health- Staten Island University Hospital, Staten Island
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07650032Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions
- Weill Cornell Medicine, New York
Recruiting
Ages 18 to 90 · All sexes · Updated Jan 26, 2026 · NCT06743789From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.